K74.0
Hepatic fibrosis
Clinical Classification Guidelines
Code First
- underlying liver disease, such as:
- nonalcoholic steatohepatitis (NASH) (K75.81)
Medical Intelligence & Overview
Hepatic fibrosis refers to the formation of excess scar tissue in the liver due to ongoing liver damage. Over time, this scar tissue can interfere with normal liver function and may progress to more severe liver conditions if not addressed. Recognizing the causes, symptoms, and available treatments can help in managing this condition effectively.
Causes & Symptoms
Clinical Causes: Chronic alcohol abuse Viral hepatitis (such as hepatitis B and C) Non-alcoholic fatty liver disease (NAFLD) Chronic drug toxicity Inherited liver disorders Autoimmune liver diseases Prolonged exposure to harmful chemicals or toxins Obesity
Key Symptoms: Fatigue and weakness Abdominal discomfort or pain in the upper right side Enlarged liver (hepatomegaly) Jaundice (yellowing of the skin and eyes) Swelling in the abdomen (ascites) Swelling in the legs and ankles Easy bruising or bleeding Unexplained weight loss or gain
Diagnostic & Treatment
Diagnosis Path: Diagnosing hepatic fibrosis involves a combination of medical history assessment, physical examination, and specialized tests. These include blood tests to check liver function, imaging studies such as ultrasound or elastography to evaluate liver stiffness, and sometimes a liver biopsy to confirm the presence and extent of scar tissue.
Treatment Protocols: While there is no specific cure for hepatic fibrosis, managing the underlying cause is essential to prevent progression. Treatment strategies include:
Clinical Advice & FAQs
Billing Guidance
Is K74.0 a billable ICD-10 code?
Yes, K74.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report K74.0?
Clinical documentation must specify the nature of Hepatic fibrosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference